Swedbank’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10M Buy
914,532
+475,122
+108% +$5.63M 0.01% 504
2026
Q2
$6.3M Buy
+439,410
New +$4.88M 0.01% 562

Other funds holding ZVRA

Swedbank's ZVRA Position: Q3 2026 in Review

Swedbank increased its Zevra Therapeutics (ZVRA) stake by 108% in Q3 2026, buying an estimated $5.63M and bringing the position to 914,532 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #504.

Swedbank first reported a position in ZVRA in Q2 2026 and has held it in 2 quarters since. 174 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Swedbank held 914,532 shares of Zevra Therapeutics worth $10M as of Q3 2026.
  • Swedbank bought 475,122 Zevra Therapeutics shares in Q3 2026, an estimated $5.63M.
  • Zevra Therapeutics made up 0.01% of Swedbank's portfolio in Q3 2026, its #504 holding.
  • Swedbank first reported a position in Zevra Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 174 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.